Compare Cipta Sarana Medika Tbk. (DKHH) vs Reksa Dana Indeks Premier ETF IDX High Dividend 20 (XIHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Reksa Dana Indeks Premier ETF IDX High Dividend 20 — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Reksa Dana Indeks Premier ETF IDX High Dividend 20 trades at Rp597 (market cap 32.38B, 13.2K 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 4.9× Reksa Dana Indeks Premier ETF IDX High Dividend 20's market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 13.2K). Which is the better fit depends on your goals.
| DKHH | XIHD | |
|---|---|---|
Market Cap | 158.12B | 32.38B |
Volume | 8.21M | 13.2K |
Lot | 82.15K | 132 |
Turnover | 515.2M | 7.79M |
Average Price | 62.72 | 590.18 |
Value | 515.2M | 7.79M |
Indicative Equilibrium Price | 63 | — |
Indicative Equilibrium Volume | 1.33K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
